back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 11:09 Tx date 2024-02-07 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,460
+13,000 vol $0.42 each |
254,422 | |
| Filed 2024-02-08 11:09 Tx date 2024-02-06 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+11,000 vol $0.40 each |
241,422 | |
| Filed 2024-02-08 11:09 Tx date 2024-02-05 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+9,000 vol $0.40 each |
230,422 | |
| Filed 2024-02-02 18:05 Tx date 2024-02-02 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+18,000 vol $0.40 each |
221,422 | |
| Filed 2024-02-02 18:05 Tx date 2024-02-01 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,485
+11,500 vol $0.39 each |
203,422 | |
| Filed 2024-02-02 18:05 Tx date 2024-01-31 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,660
+7,000 vol $0.38 each |
191,922 | |
| Filed 2024-02-02 18:04 Tx date 2024-01-30 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,340
+6,000 vol $0.39 each |
184,922 | |
| Filed 2024-02-02 18:04 Tx date 2024-01-29 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,885
+10,500 vol $0.37 each |
178,922 | |
| Filed 2024-01-26 20:23 Tx date 2024-01-26 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,488
+7,000 vol $0.3555 each |
168,422 | |
| Filed 2024-01-26 20:23 Tx date 2024-01-25 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,242
+29,000 vol $0.3532 each |
161,422 | |
| Filed 2024-01-26 20:22 Tx date 2024-01-24 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,224
+11,000 vol $0.384 each |
132,422 | |
| Filed 2024-01-26 20:22 Tx date 2024-01-23 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,326
+11,000 vol $0.3933 each |
121,422 | |
| Filed 2024-01-26 20:21 Tx date 2024-01-22 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,072
+40,000 vol $0.4018 each |
110,422 | |
| Filed 2023-06-05 10:24 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,238 vol |
382,338 | |
| Filed 2023-03-28 15:54 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-28 15:53 Tx date 2023-03-24 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+70,422 vol |
70,422 | |
| Filed 2023-03-28 15:52 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-06 17:04 Tx date 2022-10-06 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
326,100 | |
| Filed 2021-09-23 10:40 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-23 10:39 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
301,100 | ||
| Filed 2021-08-19 17:28 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-19 17:28 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
MacKay, Geoffrey Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
301,100 | ||
| Filed 2019-01-18 Tx date 2016-12-07 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
45,000 | |
| Filed 2019-01-18 Tx date 2016-08-10 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-135,000 vol |
15,000 | |
| Filed 2019-01-18 Tx date 2019-01-15 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$27,704
+58,325 vol $0.475 each |
58,325 | |
| Filed 2019-01-18 Tx date 2015-10-14 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-07 Tx date 2018-07-30 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,500
+50,000 vol $0.43 each |
200,000 | |
| Filed 2015-10-15 Tx date 2015-10-14 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,000
+150,000 vol $0.36 each |
150,000 | |
| Filed 2015-10-15 Tx date 2015-10-14 |
$RP
RepliCel Life Sciences Inc. |
MacKay, Geoffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|